<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.4'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/dispositivos-insuficiencia-cardiaca-dai-resincronizacion-fevi-qrs-esc-2026/</loc>
  <lastmod>2026-11-09T11:26:07Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Dispositivos en insuficiencia cardíaca: criterios de DAI y resincronización, umbrales de FEVI y QRS (ESC 2026)</news:title>
   <news:publication_date>2026-11-09T11:23:11Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/mcm-disfuncion-endotelial-oxido-nitrico-dia-39/</loc>
  <lastmod>2026-11-08T22:13:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Disfunción endotelial y pérdida de óxido nítrico &amp;#124; Medicina Cardiometabólica · Día 39</news:title>
   <news:publication_date>2026-11-08T22:13:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/neumotorax-semiologia-signos/</loc>
  <lastmod>2026-11-08T22:14:33Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Neumotórax: semiología y signos de gravedad</news:title>
   <news:publication_date>2026-11-08T22:13:03Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/endo-prueba-estimulacion-trh-dia-39/</loc>
  <lastmod>2026-11-08T22:12:08Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Prueba de estimulación con TRH: su lugar limitado en tiroides hoy &amp;#124; Endocrinología · Día 39</news:title>
   <news:publication_date>2026-11-08T22:12:08Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/cardio-desdoblamiento-fisiologico-s2-dia-39/</loc>
  <lastmod>2026-11-08T22:10:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Desdoblamiento fisiológico del segundo ruido con la respiración &amp;#124; Cardiología · Día 39</news:title>
   <news:publication_date>2026-11-08T22:10:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/mi-patron-hepatocelular-colestasico-dia-39/</loc>
  <lastmod>2026-11-08T22:09:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Patrón hepatocelular versus colestásico en el perfil hepático &amp;#124; Medicina Interna · Día 39</news:title>
   <news:publication_date>2026-11-08T22:09:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/eeuu-312-medicare-rehabilitacion-cardiaca/</loc>
  <lastmod>2026-11-08T16:20:40Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>¿Cubre Medicare la rehabilitación cardíaca? Requisitos y copagos</news:title>
   <news:publication_date>2026-11-08T16:20:40Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/pelacarsen-lpa-horizon-radar/</loc>
  <lastmod>2026-11-08T11:27:07Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Pelacarsen y Lp(a): Radar cardiometabólico 8 nov</news:title>
   <news:publication_date>2026-11-08T11:27:07Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/antagonistas-receptor-mineralocorticoide-insuficiencia-cardiaca-fevi-dosis-control-potasio/</loc>
  <lastmod>2026-11-08T11:11:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Antagonistas del receptor mineralocorticoide en insuficiencia cardíaca: cuál elegir según la FEVI, dosis y control de potasio (ESC 2026)</news:title>
   <news:publication_date>2026-11-08T11:11:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/mcm-inflamasoma-nlrp3-resistencia-insulina-dia-38/</loc>
  <lastmod>2026-11-07T22:14:52Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Inflamasoma NLRP3 y resistencia a la insulina &amp;#124; Medicina Cardiometabólica · Día 38</news:title>
   <news:publication_date>2026-11-07T22:14:52Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/endo-prueba-privacion-agua-dia-38/</loc>
  <lastmod>2026-11-07T22:13:09Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Prueba de privación de agua en la diabetes insípida &amp;#124; Endocrinología · Día 38</news:title>
   <news:publication_date>2026-11-07T22:12:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/sindrome-derrame-pleural-signos-clinicos/</loc>
  <lastmod>2026-11-07T22:11:51Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Derrame pleural: signos clínicos y su LR</news:title>
   <news:publication_date>2026-11-07T22:11:51Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/cardio-segundo-ruido-a2-p2-dia-38/</loc>
  <lastmod>2026-11-07T22:11:10Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Segundo ruido cardiaco: componentes aórtico y pulmonar &amp;#124; Cardiología · Día 38</news:title>
   <news:publication_date>2026-11-07T22:11:10Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/mi-pruebas-funcion-hepatica-dia-38/</loc>
  <lastmod>2026-11-07T22:09:43Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Pruebas de función hepática: transaminasas, FA y bilirrubinas &amp;#124; Medicina Interna · Día 38</news:title>
   <news:publication_date>2026-11-07T22:09:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/eeuu-311-tiotropio-para-que-sirve/</loc>
  <lastmod>2026-11-07T16:19:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Tiotropio (Spiriva Respimat, HandiHaler): para qué sirve, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-11-07T16:19:39Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/sacubitrilo-valsartan-insuficiencia-cardiaca-dosis-transicion-ieca-36-horas/</loc>
  <lastmod>2026-11-07T11:13:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Sacubitrilo/valsartán en insuficiencia cardíaca: dosis, ventana de 36 horas al cambiar de IECA y efectos adversos (ESC 2026)</news:title>
   <news:publication_date>2026-11-07T11:13:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
